R-Luxury Pharmsp. z o.o.
Overview
Financials
Industry
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 83 | $2,242.03 | 83% | |
Others | 17 | $459.21 | 17% |
Manner of representation
When disposing of a right or incurring property obligations involving a performance exceeding PLN 100,000: 1) in the case of appointing a one-person management board, the President of the Management Board is authorised to represent the company (to make declarations on behalf of the company) independently; 2) in the case of a two- or three-member management board, two members of the management board acting jointly, or a member of the management board acting jointly with a commercial proxy, are authorised to represent the company (to make declarations on behalf of the company). In other situations, each member of the management board is authorised to represent the company (to make declarations on behalf of the company) independently.
Beneficial owners
No beneficial owners recorded for the company R-Luxury Pharm.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Centrum Medyczne MedicosS.A. | $4,714,965.98 | cmmedicos.pl | ||
| Natur DayS.A. | $680,635.59 | naturday.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| Nature's Voicesp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com |
FAQ
Last updated: 2026-09-06